DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20205294

Effect of baclofen on physiotherapy in the management of spastic cerebral palsy via gross motor function measure

Tabassum Ali, Bismay Das, Chhandamayee Mohanty, Rajniti Prasad, B. K. Das, Tripti Anand

Abstract


Background: Cerebral palsy is the most common cause of physical disability in children. The gross motor function measure-66 (GMFM-66) is an observational clinical measure designed to evaluate gross motor function in children with cerebral palsy (CP). The aim of this study was to explore pediatric physiotherapists’ experiences with the gross motor capacity with CP by implementing a short-term intervention.

Methods: This study was performed in the Department of Anatomy and Department of Pediatrics, University Hospital, Banaras Hindu University, Varanasi and Kiran Society, Varanasi. Patients aged between 2 years to 14 years of both sexes satisfying the inclusion and exclusion criteria were randomly enrolled into two groups; Group A included 60 patients who received only physiotherapy and Group B included 60 patients who received baclofen along with physiotherapy. Ethical clearance was obtained from the concerned authority. Data management and statistical analysis were performed using MS excel.

Results: Percentage of spastic diplegia were 20.0% and 16.6% and percentage of spastic quadriplegia were 31.6% and 26.6% in group A and group B respectively. Before treatment mean score of GMFM for group A was increased to after 3 months of treatment and which further increased to after 6 months of treatment when compared to group B as their baseline mean score of GMFM  was after 3 months of treatment and it increased after 6 months of treatment.

Conclusions: The findings suggest the GMFM to be a useful and reliable instrument for assessing motor function and treatment outcome in CP.


Keywords


Beclofen, Cerebral palsy, GMFM, Physiotherapy

Full Text:

PDF

References


Accardo PJ. Freud on diplegia: commentary and translation. Am J Dis Children. 1982;136(5):452-6.

Nelson KB, Ellenberg JH. Antecedents of cerebral palsy-multivariant analysis. N Engl J Med. 1986;315:81-6,

Moster D, Lie RT, Irgens L, Bjerkedal T, Markestad T. The association of apgar score with subsequent death and cerebral palsy: a population-based study in term infants. J Pediatr. 2001;138:798-803.

Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109(109):8-14.

Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. The gross motor function measure: a means to evaluate the effects of physical therapy. Develop Med Child Neurol. 1989;31:341-52.

Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-23.

Lundkvist Josenby A, Jarnlo GB, Gummesson C, Nordmark E. Longitudinal construct validity of the GMFM-88 total score and goal total score and the GMFM-66 score in a 5-year follow-up study. Phys Therap. 2009;89(4):342-50.

Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys Therap. 2000;80(9):873-85.

Alotaibi M, Long T, Kennedy E, Bavishi S. The efficacy of GMFM-88 and GMFM-66 to detect changes in gross motor function in children with cerebral palsy (CP): a literature review. Disabil Rehab. 2014;36(8):617-27.

Morris C, Bartlett D. Gross motor function classification system: impact and utility. Develop Med Child Neurol. 2004;46(1):60-5.

Edgar TS. Oral pharmacotherapy of childhood movement disorder. J Child Neurol. 2003;18:40-9.

Kim KJ. Relationships between gross motor capacity and neuromusculoskeletal function in children with cerebral palsy after short-term intensive therapy. J Kor Phys Ther. 2018;30(30):90-5.

Amin MR, Saha NC, Rahman S, Hossain MS, Islam MJ, Islam MS. Efficacy of baclofen in combination with intensive rehabilitation in spastic cerebral palsy- a randomized clinical trial. J Dhaka Med Coll. 2014;23(1):18-23.

Löwing K, Bexelius A, Carlberg EB. Goal-directed functional therapy: a longitudinal study on gross motor function in children with cerebral palsy. Disabil Rehab. 2010;32(11):908-16.

Ahl LE, Johansson E, Granat T, Carlberg EB. Functional therapy for children with cerebral palsy: an ecological approach. Develop Med Child Neurol. 2005;47(9):613-9.